Methods of financing for early- and growth-stage companies are no longer following traditional courses. Young companies do not have to rely solely on dilutive capital from equity investors. Venture debt financing is a viable option for promising companies that do not yet have positive cash flow, assets to leverage, a proven credit history, or, in some cases, even revenue. A creative approach is necessary to procure the varied and innovative venture debt options that exist in today’s market.
We’re Different than Other Venture Debt Solution Providers
Lender innovation with venture debt continues to avail more options for emerging companies. Venture debt lenders are willing to assume more risk and invent new ways to grant capital to promising companies. There is also increased competition with the seemingly never-ending supply of new venture debt funds. Armentum has unmatched lender relationships and understands how to navigate the dynamic venture debt market.
We Raise Debt between $10MM and $200MM.
Unmatched Lender Relationships to Secure Venture Debt
Let’s discuss how Armentum can facilitate venture debt financing for your company.
JDS TherapeuticsSenior Debt $25,000,000
G1 TherapeuticsSenior Debt $150,000,000
ClearsenseSenior Debt $25,000,000
Mersana TherapeuticsSenior Debt $100,000,000
ViscogliosiNAV-based financing $70,000,000
Pi-CardiaSenior Debt $21,000,000
GetaroundSenior Debt $75,000,000
Eloxx PharmaceuticalsSenior Debt $30,000,000
Armentum Partners is an independent financial services firm focused on facilitating debt transactions primarily for technology and healthcare companies. We provide non-dilutive capital-raising solutions, including venture debt, middle market debt and royalty financings. Utilizing our deep industry knowledge, years of experience, and long-term, trusted relationships with lenders, we transform companies and facilitate continuous growth.